Fleet Attorney | Beasley Allen On December 11, 2008, the U.S. Food and Drug Administration (FDA) issued a Safety Alert calling for a black box warning to consumers and health care providers that a serious form of kidney injury, acute phosphate nephropathy, had been associated with the use of prescription OSP, namely Salix Pharmaceuticals' Visicol and Osmo Prep. The FDA expressed equal concern for kidney damage associated with the use of over-the-counter (OTC) products such as Fleet Phospho-soda and Fleet Accu-Prep solutions when used for bowel clearing. Fleetlawyer.net~Site InfoWhoisTrace RouteRBL Check
